BERKELEY, Calif. and VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving – an investor conference ...
BriaCell is expanding its breast cancer platform technology into other cancers including prostate, melanoma, and ...
Proceeds will be used to advance clinical and research and development pipeline and for general ...
BERKELEY, Calif. and VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...
BERKELEY, Calif. and VANCOUVER, British Columbia, June 07, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
12.0 months average overall survival benefit, including 13.4 months in patients with 2+ HLA matches ...
BERKELEY, Calif. and VANCOUVER, British Columbia, May 19, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, May 11, 2021— BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) ...
Accessibility Tools